N
EBS icon

Natixis’s Emergent Biosolutions EBS Stock Holding History

Natixis’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,827
Closed -$17.5K – 1034
2024
Q4 		$17.5K Hold
1,827
– – ﹤0.01% 941
2024
Q3 		$15.3K Hold
1,827
– – ﹤0.01% 838
2024
Q2 		$12.5K Sell
1,827
-11,273
-86% -$48.5K ﹤0.01% 833
2024
Q1 		$33.1K Sell
13,100
-27,715
-68% -$62.5K ﹤0.01% 851
2023
Q4 		$98K Sell
40,815
-253,712
-86% -$596K ﹤0.01% 777
2023
Q3 		$1M Buy
294,527
+292,700
+16,021% +$1.62M 0.01% 498
2023
Q2 		$13.4K Sell
1,827
-464
-20% -$4.3K ﹤0.01% 921
2023
Q1 		$23.7K Buy
+2,291
New +$27.7K ﹤0.01% 860
2022
Q2 		– Sell
-7,194
Closed -$295K – 1209
2022
Q1 		$295K Sell
7,194
-318
-4% -$14K ﹤0.01% 1066
2021
Q4 		$327K Sell
7,512
-25,950
-78% -$1.17M ﹤0.01% 1118
2021
Q3 		$1.68M Buy
33,462
+23,109
+223% +$1.4M 0.01% 764
2021
Q2 		$652K Sell
10,353
-670
-6% -$43K ﹤0.01% 669
2021
Q1 		$1.02M Buy
11,023
+278
+3% +$28.5K ﹤0.01% 828
2020
Q4 		$963K Buy
+10,745
New +$986K ﹤0.01% 808
2017
Q4 		– Sell
-5,018
Closed -$203K – 919
2017
Q3 		$203K Buy
+5,018
New +$182K ﹤0.01% 1123
2016
Q2 		– Sell
-5,651
Closed -$205K – 412
2016
Q1 		$205K Buy
+5,651
New +$200K ﹤0.01% 284

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Natixis's EBS Position: Q1 2025 in Review

Natixis sold out of Emergent Biosolutions (EBS) in Q1 2025, closing a stake of 1,827 shares — an estimated $17.5K sold.

Natixis first reported a position in EBS in Q1 2016 and held it in 16 quarters. The position peaked at $1.68M in Q3 2021. 160 funds tracked by Wall St. Rank hold EBS as of Q1 2025.

  • Natixis reported no remaining Emergent Biosolutions position as of Q1 2025 after selling out during the quarter.
  • Natixis sold 1,827 Emergent Biosolutions shares in Q1 2025, an estimated $17.5K.
  • Natixis first reported a position in Emergent Biosolutions in Q1 2016 and held it in 16 quarters.
  • Natixis's Emergent Biosolutions position peaked at $1.68M in Q3 2021.
  • 160 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2025.

Based on Natixis's 13F filing for Q1 2025, filed 14 May 2025.